Abstract
Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 180-183 |
| Number of pages | 4 |
| Journal | Point of Care |
| Volume | 11 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2012 |
Fingerprint
Keywords
- acute kidney injury
- acute myocardial infarction
- biomarker
- cardiac biomarker
- crush injury
- neutrophil gelatinase-associated lipocalin
- pathogen detection
- robustness
- sepsis
- turnaround time
ASJC Scopus subject areas
- Nursing(all)
Cite this
Point-of-care testing at the disaster-emergency-critical care interface. / Tran, Nam; Godwin, Zachary; Bockhold, Jennifer; Kost, Gerald J.
In: Point of Care, Vol. 11, No. 4, 12.2012, p. 180-183.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Point-of-care testing at the disaster-emergency-critical care interface
AU - Tran, Nam
AU - Godwin, Zachary
AU - Bockhold, Jennifer
AU - Kost, Gerald J
PY - 2012/12
Y1 - 2012/12
N2 - Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.
AB - Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.
KW - acute kidney injury
KW - acute myocardial infarction
KW - biomarker
KW - cardiac biomarker
KW - crush injury
KW - neutrophil gelatinase-associated lipocalin
KW - pathogen detection
KW - robustness
KW - sepsis
KW - turnaround time
UR - http://www.scopus.com/inward/record.url?scp=84870445589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870445589&partnerID=8YFLogxK
U2 - 10.1097/POC.0b013e318265f7d9
DO - 10.1097/POC.0b013e318265f7d9
M3 - Article
AN - SCOPUS:84870445589
VL - 11
SP - 180
EP - 183
JO - Point of Care
JF - Point of Care
SN - 1533-029X
IS - 4
ER -